SLS

Sellas Life Sciences Group, Inc.

$4.77-0.11 (-2.25%)
Price
MA20
Insider buy
Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5

Galena Biopharma, Inc. (GALE) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.

Latest Insider Transactions

Showing 10 of 14 transactions (past 365 days)

SLS
CDO
Award
$0
Cicic Dragan300,000 shares @ $0.00
Filed 2026-01-09Trade 2026-01-07
SLS
Director
Award
$0
Van Nostrand Robert L50,000 shares @ $0.00
Filed 2026-01-09Trade 2026-01-07
SLS
Director
Award
$0
Wasman Jane50,000 shares @ $0.00
Filed 2026-01-09Trade 2026-01-07
SLS
Director
Award
$0
Scheinberg David A50,000 shares @ $0.00
Filed 2026-01-09Trade 2026-01-07
SLS
CFO
Award
$0
Burns John Thomas300,000 shares @ $0.00
Filed 2026-01-09Trade 2026-01-07
SLS
Director
Award
$0
Varian John50,000 shares @ $0.00
Filed 2026-01-09Trade 2026-01-07
SLS
Director
Award
$0
Kalin Katherine Bach50,000 shares @ $0.00
Filed 2026-01-09Trade 2026-01-07
SLS
CEO
Other
-$280.6K
Stergiou Angelos M.187,066 shares @ $1.50
Filed 2025-12-05Trade 2025-12-03
SLS
CFO
Other
-$87.9K
Burns John Thomas58,592 shares @ $1.50
Filed 2025-12-05Trade 2025-12-03
SLS
CDO
Other
-$95.7K
Cicic Dragan63,800 shares @ $1.50
Filed 2025-12-05Trade 2025-12-03

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.

Cluster Buy Signals →All Insider Signals →Top Insider Buying →